Ovarian carcinoma: Quantitative biexponential MR imaging relaxometry reveals the dynamic recruitment of ferritin-expressing fibroblasts to the angiogenic rim of tumors

Radiology

Volumn 268, Issue 3, 2013, Pages 790-801

  Vandsburger, Moriel H ^a   Radoul, Marina ^a   Addadi, Yoseph ^a   Mpofu, Senzeni ^a   Cohen, Batya ^a   Eilam, Raya ^a   Neeman, Michal ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; FERRITIN; GADOLINIUM PENTETATE MEGLUMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VOLUME; CANCER CELL; CARCINOMA CELL; CELL DENSITY; CELL FRACTIONATION; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; FIBROBLAST; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; IRON TRANSPORT; MAGNETIC RESONANCE RELAXOMETRY; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; VALIDITY;

ANIMALS; CELL LINE, TUMOR; CELL TRACKING; FEMALE; FERRITINS; FIBROBLASTS; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS;

EID: 84883151285     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.13122053     Document Type: Article

References (32)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144(5): 646-674.
2. Kidd S, Spaeth E, Watson K, et al. Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma. PLoS ONE 2012;7(2):e30563.
3. Cai J, Tang H, Xu L, et al. Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness. Carcinogenesis 2012;33(1): 20-29.
4. Cirri P, Chiarugi P. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cancer Metastasis Rev 2012;31(1-2): 195-208.
5. Sherman EJ, Lim SH, Ho AL, et al. Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review. Radiother Oncol 2011;101(3): 425-430.
6. Schmitt J, Matei D. Targeting angiogenesis in ovarian cancer. Cancer Treat Rev 2012;38(4): 272-283.
7. Shapiro EM, Skrtic S, Koretsky AP. Sizing it up: cellular MRI using micron-sized iron oxide particles. Magn Reson Med 2005;53(2): 329-338.
8. Cromer Berman SM, Walczak P, Bulte JW. Tracking stem cells using magnetic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011;3(4): 343-355.
9. Cromer Berman SM, Kshitiz, Wang CJ, et al. Cell motility of neural stem cells is reduced after SPIO-labeling, which is mitigated after exocytosis. Magn Reson Med 2013;69(1): 255-262.
10. Bhagavathula N, Dame MK, DaSilva M, et al. Fibroblast response to gadolinium: role for platelet-derived growth factor receptor. Invest Radiol 2010;45(12): 769-777.
11. Winter EM, Hogers B, van der Graaf LM, Gittenberger-de Groot AC, Poelmann RE, van der Weerd L. Cell tracking using iron oxide fails to distinguish dead from living transplanted cells in the infarcted heart. Magn Reson Med 2010;63(3): 817-821.
12. Gilad AA, Winnard PT Jr, van Zijl PC, Bulte JW. Developing MR reporter genes: promises and pitfalls. NMR Biomed 2007;20(3): 275-290.
13. Gilad AA, Ziv K, McMahon MT, van Zijl PC, Neeman M, Bulte JW. MRI reporter genes. J Nucl Med 2008;49(12): 1905-1908.
14. Koretsky A, Lin Y, Schorle H, Jaenisch R. Genetic control of MRI contrast by expression of the transferrin receptor [abstr]. In: Proceedings of the Fourth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, April 27-May 3, 1996; New York, NY.
15. Cohen B, Dafni H, Meir G, Harmelin A, Neeman M. Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia 2005;7(2): 109-117.
16. Cohen B, Ziv K, Plaks V, et al. MRI detection of transcriptional regulation of gene expression in transgenic mice. Nat Med 2007;13(4): 498-503.
17. Vande Velde G, Rangarajan JR, Toelen J, et al. Evaluation of the specificity and sensitivity of ferritin as an MRI reporter gene in the mouse brain using lentiviral and adeno-associated viral vectors. Gene Ther 2011;18(6): 594-605.
18. Vande Velde G, Raman Rangarajan J, Vreys R, et al. Quantitative evaluation of MRIbased tracking of ferritin-labeled endogenous neural stem cell progeny in rodent brain. Neuroimage 2012;62(1): 367-380.
19. Iordanova B, Robison CS, Goins WF, Ahrens ET. Single chain ferritin chimera as an improved MRI gene reporter. Prilozi 2010;31(2): 151-155.
20. Iordanova B, Robison CS, Ahrens ET. Design and characterization of a chimeric ferritin with enhanced iron loading and transverse NMR relaxation rate. J Biol Inorg Chem 2010;15(6): 957-965.
21. Iordanova B, Ahrens ET. In vivo magnetic resonance imaging of ferritin-based reporter visualizes native neuroblast migration. Neuroimage 2012;59(2): 1004-1012.
22. Ziv K, Meir G, Harmelin A, Shimoni E, Klein E, Neeman M. Ferritin as a reporter gene for MRI: chronic liver over expression of H-ferritin during dietary iron supplementation and aging. NMR Biomed 2010;23(5): 523-531.
23. Campan M, Lionetti V, Aquaro GD, et al. Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5-T cardiac MRI in a rat model of myocardial infarction. Am J Physiol Heart Circ Physiol 2011;300(6):H2238- H2250.
24. Naumova AV, Reinecke H, Yarnykh V, Deem J, Yuan C, Murry CE. Ferritin overexpression for noninvasive magnetic resonance imaging-based tracking of stem cells transplanted into the heart. Mol Imaging 2010;9(4): 201-210.
25. Granot D, Addadi Y, Kalchenko V, Harmelin A, Kunz-Schughart LA, Neeman M. In vivo imaging of the systemic recruitment of fibroblasts to the angiogenic rim of ovarian carcinoma tumors. Cancer Res 2007;67(19): 9180-9189.
26. Dafni H, Gilead A, Nevo N, Eilam R, Harmelin A, Neeman M. Modulation of the pharmacokinetics of macromolecular contrast material by avidin chase: MRI, optical, and inductively coupled plasma mass spectrometry tracking of triply labeled albumin. Magn Reson Med 2003;50(5): 904-914.
27. Dafni H, Landsman L, Schechter B, Kohen F, Neeman M. MRI and fluorescence microscopy of the acute vascular response to VEGF165: vasodilation, hyper-permeability and lymphatic uptake, followed by rapid inactivation of the growth factor. NMR Biomed 2002;15(2): 120-131.
28. Naumova AV, Yarnykh VL, Balu N, Reinecke H, Murry CE, Yuan C. Quantification of MRI signal of transgenic grafts overexpressing ferritin in murine myocardial infarcts. NMR Biomed 2012;25(10): 1187-1195.
29. He T, Gatehouse PD, Smith GC, Mohiaddin RH, Pennell DJ, Firmin DN. Myocardial T2* measurements in iron-overloaded thalassemia: An in vivo study to investigate optimal methods of quantification. Magn Reson Med 2008;60(5): 1082-1089.
30. Ababneh Z, Beloeil H, Berde CB, Gambarota G, Maier SE, Mulkern RV. Biexponential parameterization of diffusion and T2 relaxation decay curves in a rat muscle edema model: decay curve components and water compartments. Magn Reson Med 2005;54(3): 524-531.
31. Loeffler M, Krüger JA, Niethammer AG, Reisfeld RA. Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. J Clin Invest 2006;116(7): 1955-1962.
32. Brennen WN, Isaacs JT, Denmeade SR. Rationale behind targeting fibroblast activation protein-expressing carcinomaassociated fibroblasts as a novel chemotherapeutic strategy. Mol Cancer Ther 2012;11(2): 257-266.